Imagion Biosystems Limited
IBXXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.7M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.70 Million |
|---|---|
| Enterprise Value | $4.86 Million |
| Earnings per Share | $-0.02 |
| Beta | -0.21 |
| Outstanding Shares | 490,471,687 |
Return
| Return on Equity | 199.77% |
|---|---|
| Return on Assets | -1016.59% |
| Return on Invested Capital | 165.33% |
Valuation & Multiples
| P/E Ratio | -0.44 |
|---|---|
| PEG | -2.3 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 4.6 |
| Enterprise Value to EBIT | -0.86 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | -0.64 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Imagion Biosystems Limited
11 employees
CEO: Robert Romeo Proulx
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using ...